ConductScience.org, home

Paper28076844

Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.

Li QQ and 8 others. Oncotarget, 2017. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. Papers, record 28076844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28076844

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
PubMed
Journal
Oncotarget
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.62
iCite
Revised in PubMed
2021-12-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li QQQian-Qian
2Xie YKYou-Ke
3Wu YYue
4Li LLLin-Lin
5Liu YYing
6Miao XBXiao-Bo
7Liu QZQiu-Zhen
8Yao KTKai-Tai
9Xiao GHGuang-Hui

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
IsothiocyanatesMajor topic
Lung NeoplasmsMajor topic
MicroRNAsMajor topic
Neoplastic Stem CellsMajor topic
Proto-Oncogene Proteins c-mycMajor topic
3' Untranslated Regions
A549 Cells
Animals
Antineoplastic Agents
Blotting, Western
Cell Line
Cell Line, Tumor
Cell Survival
Cisplatin
Down-Regulation
Doxorubicin
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Humans
Mice, Inbred BALB C
Mice, Nude
Reverse Transcriptase Polymerase Chain Reaction
Sulfoxides
Xenograft Model Antitumor Assays
beta Catenin

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117157785Radiation resistance and stem-like cells in brain tumors.Cancer Cell2006https://conductscience.org/library/papers/17157785PubMed
216064138Transcriptional regulation and transformation by Myc proteins.Nat Rev Mol Cell Biol2005https://conductscience.org/library/papers/16064138PubMed
39727977Identification of c-MYC as a target of the APC pathway.Science1998https://conductscience.org/library/papers/9727977PubMed
415944709c-Myc-regulated microRNAs modulate E2F1 expression.Nature2005https://conductscience.org/library/papers/15944709PubMed
518829980Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.Gut2009https://conductscience.org/library/papers/18829980PubMed
610499637Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.Clin Cancer Res1999https://conductscience.org/library/papers/10499637PubMed
719276181Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.Mol Cancer Res2009https://conductscience.org/library/papers/19276181PubMed
811221849A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.Cancer Res2001https://conductscience.org/library/papers/11221849PubMed
920388854Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.Clin Cancer Res2010https://conductscience.org/library/papers/20388854PubMed
1021466425Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies.Curr Pharm Biotechnol2012https://conductscience.org/library/papers/21466425PubMed
1119805294Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19805294PubMed
129858526c-Myc target genes involved in cell growth, apoptosis, and metabolism.Mol Cell Biol1999https://conductscience.org/library/papers/9858526PubMed
1319474385Cancer statistics, 2009.CA Cancer J Clin2009https://conductscience.org/library/papers/19474385PubMed
1418049477Identification and expansion of the tumorigenic lung cancer stem cell population.Cell Death Differ2008https://conductscience.org/library/papers/18049477PubMed
1526234674Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.Oncogene2016https://conductscience.org/library/papers/26234674PubMed
1617134937Sulforaphane as a promising molecule for fighting cancer.Mutat Res2007https://conductscience.org/library/papers/17134937PubMed
1718716624Modelling Myc inhibition as a cancer therapy.Nature2008https://conductscience.org/library/papers/18716624PubMed
1818371393ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell2007https://conductscience.org/library/papers/18371393PubMed
1916904174Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell2006https://conductscience.org/library/papers/16904174PubMed
2022962603MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.PLoS One2012https://conductscience.org/library/papers/22962603PubMed

See all 45 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
41594902Sulforaphane as a Multi-Scale Mechano-Modulator in Cancer: An Integrative Perspective.Biology (Basel)2026https://conductscience.org/library/papers/41594902PubMed
41060333Sulforaphane from broccoli, an epigenetic modulator in cancer cells.Discov Oncol2025https://conductscience.org/library/papers/41060333PubMed
39760839Synergistic Inhibition of Breast Carcinoma Cell Proliferation by Quercetin and Sulforaphane via Activation of the ERK/MAPK Pathway.Cell Biochem Biophys2025https://conductscience.org/library/papers/39760839PubMed
39519082Sulforaphane Attenuates Ethanol-Induced Teratogenesis and Dysangiogenesis in Zebrafish Embryos.Int J Mol Sci2024https://conductscience.org/library/papers/39519082PubMed
38972997MicroRNAs and the Mediterranean diet: a nutri-omics perspective for lung cancer.J Transl Med2024https://conductscience.org/library/papers/38972997PubMed
38892270Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis.Int J Mol Sci2024https://conductscience.org/library/papers/38892270PubMed
38474751Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.Nutrients2024https://conductscience.org/library/papers/38474751PubMed
38254735Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review.Cancers (Basel)2024https://conductscience.org/library/papers/38254735PubMed
36933561A complex microRNA regulatory network may control the HCP5/UTP3/c-Myc/VAMP3 signaling axis.Mol Ther2023https://conductscience.org/library/papers/36933561PubMed
36776295Sulforaphane: An emergent anti-cancer stem cell agent.Front Oncol2023https://conductscience.org/library/papers/36776295PubMed
36498571Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy.J Clin Med2022https://conductscience.org/library/papers/36498571PubMed
35957877The metabolic addiction of cancer stem cells.Front Oncol2022https://conductscience.org/library/papers/35957877PubMed
35886942MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.Int J Mol Sci2022https://conductscience.org/library/papers/35886942PubMed
34946741Caffeine Induces G0/G1 Cell Cycle Arrest and Inhibits Migration through Integrin αv, β3, and FAK/Akt/c-Myc Signaling Pathway.Molecules2021https://conductscience.org/library/papers/34946741PubMed
34832864
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma.
Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34832864PubMed
34295245Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.Front Pharmacol2021https://conductscience.org/library/papers/34295245PubMed
33925297Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling.Cells2021https://conductscience.org/library/papers/33925297PubMed
33672261Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.Int J Mol Sci2021https://conductscience.org/library/papers/33672261PubMed
33183321Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells.Diagn Pathol2020https://conductscience.org/library/papers/33183321PubMed
33055265Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates.Cancer Prev Res (Phila)2021https://conductscience.org/library/papers/33055265PubMed

See all 35 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28076844

GET https://conductscience.org/api/papers/v1/28076844/references?page=2